NCT07155187
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07155187
Title A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AbbVie
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ISR | AUS

Facility Status City State Zip Country Details
Highlands Oncology Group - Springdale /ID# 277132 RECRUITING Springdale Arkansas 72762 United States Details
Nho - Revive Research Institute /ID# 277569 RECRUITING Lincoln Nebraska 68506 United States Details
Tennessee Cancer Specialists - Knoxville - Old Weisgarber Road /ID# 277891 RECRUITING Knoxville Tennessee 37909 United States Details
Mater Hospital Brisbane /ID# 276985 RECRUITING South Brisbane Queensland 4101 Australia Details
Icon Cancer Centre Hobart /ID# 277549 RECRUITING Hobart Tasmania 7000 Australia Details
St Vincent's Hospital Melbourne /ID# 277002 RECRUITING Fitzroy Victoria 03065 Australia Details
Sunshine Hospital /ID# 276894 RECRUITING St Albans Victoria 3021 Australia Details
Meir Medical Center /ID# 277289 RECRUITING Kfar Saba Central District 4428164 Israel Details
Rambam Health Care Campus /ID# 276746 RECRUITING Haifa 3525408 Israel Details
Kitasato University Hospital /ID# 277241 RECRUITING Sagamihara-shi Kanagawa 252-0375 Japan Details
National Cancer Center Hospital /ID# 277093 RECRUITING Chuo-Ku Tokyo 104-0045 Japan Details
Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 277138 RECRUITING Kaohsiung City 807 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field